Cargando…

Flow cytometry assessment of reactive T‐cells distinguishes classic Hodgkin lymphoma from benign lymphadenopathy in children

BACKGROUND: Detection of classic Hodgkin lymphoma (cHL) neoplastic cells using flow cytometric immunophenotyping (FCI) remains limited. We hypothesized that characterization of the reactive infiltrates could assist in diagnosing cHL in children. METHODS: FCI using four‐color staining approaches was...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Hui, Cai, Fengqing, Liu, Lei, Shen, Hongqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550978/
https://www.ncbi.nlm.nih.gov/pubmed/35989518
http://dx.doi.org/10.1002/jcla.24661
_version_ 1784805995307859968
author Gao, Hui
Cai, Fengqing
Liu, Lei
Shen, Hongqiang
author_facet Gao, Hui
Cai, Fengqing
Liu, Lei
Shen, Hongqiang
author_sort Gao, Hui
collection PubMed
description BACKGROUND: Detection of classic Hodgkin lymphoma (cHL) neoplastic cells using flow cytometric immunophenotyping (FCI) remains limited. We hypothesized that characterization of the reactive infiltrates could assist in diagnosing cHL in children. METHODS: FCI using four‐color staining approaches was performed on 156 lymph node specimens with the following histopathologic diagnoses: cHL (25 cases), reactive lymphoid hyperplasia (RLH, 44 cases), and non‐Hodgkin lymphoma (87 cases). RESULTS: The overall concordance of FCI data with the histopathologic results of these cases was 81.4%. A reactive expansion of T‐cells with increased expression of CD45RO was present in the reactive infiltrate of cHL (CD45RO/CD3, 67.5%) and Epstein–Barr virus (EBV) infected RLH (62.7%) but not in EBV‐negative RLH (28.0%). The mean fluorescence intensity (MFI) of CD7 was higher for cHL and differed significantly from EBV‐positive RLH (138.5 vs. 63.8). A proposed diagnostic algorithm markedly elevated the overall concordance rate from 81.4% to 97.4%. CONCLUSIONS: Immunophenotyping the reactive infiltrate of lymphoid tissue using flow cytometry is a reliable supplement to histopathology for the rapid diagnosis of pediatric cHL.
format Online
Article
Text
id pubmed-9550978
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95509782022-10-14 Flow cytometry assessment of reactive T‐cells distinguishes classic Hodgkin lymphoma from benign lymphadenopathy in children Gao, Hui Cai, Fengqing Liu, Lei Shen, Hongqiang J Clin Lab Anal Research Articles BACKGROUND: Detection of classic Hodgkin lymphoma (cHL) neoplastic cells using flow cytometric immunophenotyping (FCI) remains limited. We hypothesized that characterization of the reactive infiltrates could assist in diagnosing cHL in children. METHODS: FCI using four‐color staining approaches was performed on 156 lymph node specimens with the following histopathologic diagnoses: cHL (25 cases), reactive lymphoid hyperplasia (RLH, 44 cases), and non‐Hodgkin lymphoma (87 cases). RESULTS: The overall concordance of FCI data with the histopathologic results of these cases was 81.4%. A reactive expansion of T‐cells with increased expression of CD45RO was present in the reactive infiltrate of cHL (CD45RO/CD3, 67.5%) and Epstein–Barr virus (EBV) infected RLH (62.7%) but not in EBV‐negative RLH (28.0%). The mean fluorescence intensity (MFI) of CD7 was higher for cHL and differed significantly from EBV‐positive RLH (138.5 vs. 63.8). A proposed diagnostic algorithm markedly elevated the overall concordance rate from 81.4% to 97.4%. CONCLUSIONS: Immunophenotyping the reactive infiltrate of lymphoid tissue using flow cytometry is a reliable supplement to histopathology for the rapid diagnosis of pediatric cHL. John Wiley and Sons Inc. 2022-08-21 /pmc/articles/PMC9550978/ /pubmed/35989518 http://dx.doi.org/10.1002/jcla.24661 Text en © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Gao, Hui
Cai, Fengqing
Liu, Lei
Shen, Hongqiang
Flow cytometry assessment of reactive T‐cells distinguishes classic Hodgkin lymphoma from benign lymphadenopathy in children
title Flow cytometry assessment of reactive T‐cells distinguishes classic Hodgkin lymphoma from benign lymphadenopathy in children
title_full Flow cytometry assessment of reactive T‐cells distinguishes classic Hodgkin lymphoma from benign lymphadenopathy in children
title_fullStr Flow cytometry assessment of reactive T‐cells distinguishes classic Hodgkin lymphoma from benign lymphadenopathy in children
title_full_unstemmed Flow cytometry assessment of reactive T‐cells distinguishes classic Hodgkin lymphoma from benign lymphadenopathy in children
title_short Flow cytometry assessment of reactive T‐cells distinguishes classic Hodgkin lymphoma from benign lymphadenopathy in children
title_sort flow cytometry assessment of reactive t‐cells distinguishes classic hodgkin lymphoma from benign lymphadenopathy in children
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550978/
https://www.ncbi.nlm.nih.gov/pubmed/35989518
http://dx.doi.org/10.1002/jcla.24661
work_keys_str_mv AT gaohui flowcytometryassessmentofreactivetcellsdistinguishesclassichodgkinlymphomafrombenignlymphadenopathyinchildren
AT caifengqing flowcytometryassessmentofreactivetcellsdistinguishesclassichodgkinlymphomafrombenignlymphadenopathyinchildren
AT liulei flowcytometryassessmentofreactivetcellsdistinguishesclassichodgkinlymphomafrombenignlymphadenopathyinchildren
AT shenhongqiang flowcytometryassessmentofreactivetcellsdistinguishesclassichodgkinlymphomafrombenignlymphadenopathyinchildren